drugs Class III Updated 2014-12-31

Hospira Inc. recalls Dacarbazine, Injection, USP, 200mg, vials packaged in indiv

Recalled Product

Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.


Hazard / Issue

Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: Lot #: B032223AA; Exp: July 2016
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →